Serum sST2: key biomarker in COVID-19 patients with implications for coronary artery disease
Admission serum sST2 levels should be considered in COVID-19 patients with CAD-like symptoms for treatment planning and could serve as a prognostic biomarker for COVID-19 with co-existing CAD in clinical practice.
Authors
- Cheng Jin-fang
- Xueqin Li (ORCID: https://orcid.org/0000-0001-5270-4825)
- Hongyan Cao (ORCID: https://orcid.org/0009-0004-0799-5546)
- Yaxin Tian
Institutions
- Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s12879-025-10849-y
- Citations
- 1
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.80